Limoneira predicts sales gains after profits dip
Santa Paula-based Limoneira Co. said fourth-quarter revenue jumped sharply but that it experienced a decline in profit because of expenses for Sheldon Ranch, a new 1,000-acre lemon and citrus leasehold that is expected to be profitable in 2013. The company said it expects strong results from those lemon and citrus in 2013, when it also Read More →
Amgen inks $180M nanomedicine deal
Thousand Oaks-based Amgen has entered a deal to pay up to $180.5 million for nanomedicine tumor treatments being developed by a Massachusetts company. Cambridge-based Bind Biosciences said it has entered a development agreement with Amgen for its kinase inhibitor nanomedicines for treating a range of solid tumors. The medicines are highly targeted and can be Read More →
CalAmp buys Wireless Matrix for $53M
Oxnard-based wireless products company CalAmp Corp. said Dec. 20 that it is buying the U.S. operations of Wireless Matrix Corp. for $53 million in cash. CalAmp said it expects the deal, which will likely close in the first quarter of 2013, to be accretive to its non-GAAP earnings starting in 2014. Wireless Matrix is a Read More →
QAD buys Michigan firm for $5M
Santa Barbara-based manufacturing software firm QAD said Dec. 31 that it purchased Michigan-based Cebos for $5 million in cash. QAD sells planning and management software used by large manufacturing firms around the world. Cebos provides management and regulatory compliance software. QAD will pay $3.5 million upon closing the deal and then $1.5 million subject to Read More →
Ryland plots a comeback: Homebuilder expects first profitable year since 2006
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen buys DeCode Genetics for $415M
Biotech giant Amgen is buying Icelandic genetics research firm DeCode Genetics for $415 million, the Thousand Oaks company said Dec. 10. The all-cash deal is expected to close before the end of the year and will give Amgen, the largest biotechnology firm in the world, opportunities to develop new medicines that target defective DNA. “DeCode Read More →
